lauric acid is a lipid of Fatty Acyls (FA) class. Lauric acid is associated with abnormalities such as Infection, Renal tubular disorder, Hypertensive disease, Obesity and Mycoses. The involved functions are known as Transcription, Genetic, Signal Transduction, Mutation, metaplastic cell transformation and Anabolism. Lauric acid often locates in Skin, Plasma membrane, Cytoplasmic matrix, Body tissue and Palmar surface. The associated genes with lauric acid are Gene Family, SLC33A1 gene, Homologous Gene, Open Reading Frames and P4HTM gene. The related lipids are Fatty Acids, Oleic Acids, Palmitates, Stearates and 9,11-linoleic acid.
To understand associated biological information of lauric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
lauric acid is suspected in Renal tubular disorder, Hypertensive disease, Infection, Renal vascular disorder, Obesity, Mycoses and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with lauric acid
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Kaffarnik H and Meyer-Bertenrath JG | [Pancreas specificity of the oral function test using fluorescein di-or. monolaurate, respectively]. | 1971 | Verh Dtsch Ges Inn Med | pmid:5155888 |
Lapidot Y et al. | Use of esters of N-hydroxysuccinimide in the synthesis of N-acylamino acids. | 1967 | J. Lipid Res. | pmid:14564721 |
BLANK IH and GOULD E | Penetration of anionic surfactants into skin. III. Penetration from buffered sodium laurate solutions. | 1961 | J. Invest. Dermatol. | pmid:13869837 |
CARLESS JE and NIXON JR | The oxidation of solubilised and emulsified oils. Part III. The oxidation of methyl linoleate in potassium laurate and cetomacrogol dispersions. | 1960 | J. Pharm. Pharmacol. | pmid:13807717 |
CARLESS JE and NIXON JR | The oxidation of solubilised and emulsified oils. Part II. Solubility of benzaldehyde, cyclohexene and methyl linoleate in potassium laurate and cetomacrogol solutions. | 1960 | J. Pharm. Pharmacol. | pmid:13807716 |
BLANK IH and GOULD E | Penetration of anionic surfactants (surface active agents) into skin. I. Penetration of sodium laurate and sodium dodecyl sulfate into excised human skin. | 1959 | J. Invest. Dermatol. | pmid:13801318 |
CARLESS JE and NIXON JR | The oxidation of solubilised and emulsified oils. I. Oxidation of benzaldehyde in potassium laurate and cetomacrogol dispersions. | 1957 | J. Pharm. Pharmacol. | pmid:13492185 |
VAN DE KAMER JH et al. | Gas-liquid partition chromatography: the separation and micro-estimation of volatile fatty acids from formic acid to dodecanoic acid. | 1955 | Biochem. J. | pmid:13260193 |
BEAN HS and BERRY H | The bactericidal activity of phenols in aqueous solutions of soap. III. The bactericidal activity of chloroxylenol in aqueous solutions of potassium laurate. | 1953 | J. Pharm. Pharmacol. | pmid:13085294 |
JAMES AT and MARTIN AJ | Gas-liquid partition chromatography; the separation and micro-estimation of volatile fatty acids from formic acid to dodecanoic acid. | 1952 | Biochem. J. | pmid:14934673 |
BEAN HS and BERRY H | The bactericidal activity of phenols in aqueous solutions of soap. II. The bactericidal activity of benzylchlorophenol in aqueous solutions of potassium laurate. | 1951 | J. Pharm. Pharmacol. | pmid:14874199 |
MIBASHAN-SHARAGA L | [Not Available]. | 1949 | C. R. Hebd. Seances Acad. Sci. | pmid:18118491 |
VIVINO AE and KOPPANYI T | The effect of continued oral administration of lauric and myristic acid ester of colaminoformylmethylpyridinium chloride (emulsept) to the albino rat. | 1946 | J Am Pharm Assoc Am Pharm Assoc | pmid:20989213 |
BISCHOFF F | The influence of sodium lauryl sulfate on the biologic response to the gonadotropins and to insulin. | 1945 | Am. J. Physiol. | pmid:21009247 |
NEGRE L and BERTHELOT A | [Not available]. | 1945 | Ann Inst Pasteur (Paris) | pmid:21021178 |
Cravedi JP and Perdu-Durand E | The phthalate diesters DEHP and DBP do not induce lauric acid hydroxylase activity in rainbow trout. | Mar. Environ. Res. | pmid:12408651 | |
Bozcaarmutlu A and Arinç E | Purification of CYP2B-like protein from feral leaping mullet (Liza saliens) liver microsomes and its biocatalytic, molecular, and immunological characterization. | J. Biochem. Mol. Toxicol. | pmid:18752317 | |
pmid:16771408 | ||||
Matsumoto K et al. | Synergistic effects of Glu130Asp substitution in the type II polyhydroxyalkanoate (PHA) synthase: enhancement of PHA production and alteration of polymer molecular weight. | Biomacromolecules | pmid:15638509 | |
Elder JP | Introduction of Cheryl L. Perry, recipient of the 2004 Research Laureate Medallion. | Am J Health Behav | pmid:15569590 |